Ananda Developments completes GBP2 million placing and subscription

(Alliance News) - Ananda Developments PLC said on Monday it had completed a GBP2.1 million ...

Alliance News 9 September, 2024 | 3:32PM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Ananda Developments PLC said on Monday it had completed a GBP2.1 million placing and subscription, which will be used to fund further research for the company.

The London-based life sciences company is focused on the research and clinical development of cannabinoid-based therapies for a range of complex inflammatory pain conditions.

Ananda Developments raised gross proceeds of GBP2.1 million through a placing and subscription of new ordinary shares at 0.30 pence each. This included a GBP2 million subscription by Charles Morgan, the company's chair.

The net proceeds from the placing and subscription will be put towards the manufacture of the MRX1 drug candidate for chemotherapy induced peripheral neuropathy & endometriosis phase II studies; the execution of a pharmacokinetic study for MRX1 in Australia; further pre-clinical heart fibrosis with ejection fraction studies, and general working capital.

Morgan and Melissa Sturgess, chief executive officer, also agreed to capitalise all unsecured debt owed to them, subject to additional share authorities being granted at an upcoming general meeting. This will "significantly strengthen the company's balance sheet", Ananda said.

Chief Executive Officer Melissa Sturgess said: "This significant equity investment from the company's chairmen and other investors places us in a very strong position to progress our clinical trials and achieve significant value accretive milestones. We look forward to updating shareholders with our progress and remain committed to getting our MRX1 drug candidate through the trials, through licensing and into the NHS and other licenced drug markets."

Ananda intends to issue up to 33.3 million new shares to existing shareholders this month via the Winterflood Retail Access Platform to raise up to GBP100,000.

Shares in Ananda Developments last traded at 0.35 pence each on AQSE in London on Monday afternoon.

By Emily Parsons, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Ananda Developments PLC Ordinary Shares 0.38 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures